PMC:7029759 / 18363-18732
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 400 | 72-76 | Gene | denotes | ACE2 | Gene:59272 |
| 401 | 119-123 | Gene | denotes | ACE2 | Gene:59272 |
| 405 | 31-40 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 406 | 155-166 | Species | denotes | coronavirus | Tax:11118 |
| 408 | 150-154 | Species | denotes | NL63 | Tax:277944 |
| 413 | 22-26 | Disease | denotes | SARS | MESH:D045169 |
| 414 | 141-145 | Disease | denotes | SARS | MESH:D045169 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T381 | 22-26 | SP_10 | denotes | SARS |
| T380 | 31-40 | SP_7 | denotes | 2019-nCoV |
| T379 | 56-68 | SO:0000409 | denotes | binding site |
| T378 | 72-76 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T377 | 119-123 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T376 | 124-137 | SO:0000409 | denotes | binding sites |
| T375 | 141-145 | SP_10 | denotes | SARS |
| T374 | 155-166 | NCBITaxon:11118 | denotes | coronavirus |
| T373 | 247-257 | GO:0042571 | denotes | antibodies |
| T372 | 308-315 | UBERON:0000479 | denotes | tissues |
| T371 | 344-349 | NCBITaxon:10239;GO:0035376 | denotes | viral |
| T370 | 350-355 | GO:0035376 | denotes | entry |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T98 | 308-315 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T54 | 22-26 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T55 | 141-145 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T155 | 366-368 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 0-369 | Sentence | denotes | This strategy assumes SARS and 2019-nCoV share the same binding site on ACE2, which is highly likely given the similar ACE2 binding sites of SARS and NL63 coronavirus The small size of the therapy, similar in size in nanobody domains from camelid antibodies, would enhance the perfusion of the biologic into tissues to more effectively bind to viral entry receptors 45. |